International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2020 - Volume 24, Number 5
View All Articles in Issue

Page(s): 356

Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams Page 1

Download in electronic PDF format for $75

Abstract:

Related Keywords: National Academies of Sciences Engineering Medicine, NASEM Report, drug safety, drug efficacy, compounding formulations, pharmacy education, clinical pharmacy, pharmacy curriculum

Related Categories: LEGAL, QUALITY CONTROL, PHARMACY EDUCATION, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams Allen Loyd V Jr	Sep/Oct 2020 Pg. 356
NASEM Report on Compounded Topical Pain Creams Allen Loyd V Jr	Nov/Dec 2020 Pg. 446-448
PreScription: The NASEM cBHT Report, Part 2 Allen Loyd V Jr	Jan/Feb 2021 Pg. 4
PreScription: The NASEM cBHT Report, Part 1 Allen Loyd V Jr	Nov/Dec 2020 Pg. 444
Safety Standards in Pharmaceutical Compounding, Part 3: Fire Safety Allen W Chris, Greeson Nicole MH, Mixon William	Nov/Dec 2020 Pg. 451-458
FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows Brunner Scott	May/Jun 2021 Pg. 206-209
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jul/Aug 2015 Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Mar/Apr 2024 Pg. 111-116
Current Topical Treatments in Wound Healing - Part 1 Helmke Christopher D	Jul/Aug 2004 Pg. 269-274
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J	Jul/Aug 2004 Pg. 313-319
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Brunner Scott	Jul/Aug 2020 Pg. 296-297
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2 DeRosa Angela	Jan/Feb 2021 Pg. 14-17
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso	Mar/Apr 2021 Pg. 146-155
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Kochanowska-Karamyan Anna J	Sep/Oct 2016 Pg. 367-374
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance Greeson Nicole MH, Mixon William, Allan W Chris	Sep/Oct 2020 Pg. 371-379
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Ashe Krystina, Baskett Dustin	Sep/Oct 2018 Pg. 387-398
PreScription: The Past (-->2020), The Present, and The Future (2021-->) Allen Loyd V Jr	Mar/Apr 2021 Pg. 92
FDAMA Proposed List of Agents Not to be Compounded due to Withdrawal for Safety/Efficacy Concerns Allen Loyd V Jr	Jan/Feb 1999 Pg. 25-29
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr	Jan/Feb 2018 Pg. 7-16
Return to Top